Latest News
19 August 2026
Jyoti Nangalia appointed Sanger’s first Faculty Chair for Clinician Scientists
Congratulations to Dr Jyoti Nangalia, who has been appointed as the Wellcome Sanger Institute’s first Faculty Chair for Clinician Scientists. The newly created role recognises outstanding clinician scientists whose research bridges laboratory science and patient care, reflecting Jyoti’s leadership in translating genomic discoveries into a better understanding of blood cancer.
July 2026
Congratulations to Dr Kudzai Nyamondo on her promotion to Staff Scientist
Wonderful news: Dr Kudzai Nyamondo has been promoted to Staff Scientist as of July 2026. Kudzai joined the lab as a Sanger-CRUK Excellence Postdoctoral Fellow and has made outstanding contributions to our work on the clonal trajectories of blood cancers.
22 May 2026
Jyoti Nangalia elected Fellow of the Academy of Medical Sciences
Congratulations to Dr Jyoti Nangalia, who has been elected a Fellow of the Academy of Medical Sciences, one of 60 new Fellows announced this year. The honour recognises her work on how changes in DNA acquired over a person’s lifetime can drive cancer and other diseases, including her discovery of CALR mutations as a major cause of myeloproliferative neoplasms, testing for which is now recommended by the World Health Organisation.
20 April 2026
New Cancer Discovery paper on the genomic evolution of blood cancers
Excited to see our new paper out in Cancer Discovery, led by Daniel Leongamornlert with the team. The 25-year study tracked how chronic blood cancers evolve over time, showing that genetic changes can be detected years before a patient’s disease worsens. Read more about the story on the Sanger Institute website.
April 2026
Congratulations Dr Sean Laidlaw!
Huge congratulations to Sean Laidlaw, who successfully passed his PhD viva in April 2026 for his thesis, Embers of Tobacco Exposure in the Normal Airway Epigenome.
6 March 2026
Dr Jyoti Nangalia appointed Fellow at the Royal College of Physicians
Congratulations to Dr Jyoti Nangalia, who has been awarded a Fellowship at the Royal College of Physicians, one of the highest distinctions and professional recognition for clinicians in the United Kingdom. The Fellowship recognises Jyoti’s outstanding research and clinical work in cancer genomics, including her discovery of CALR mutations in myeloproliferative neoplasms and the development of Predict Blood, an NHS-hosted tool for personalised blood cancer prognosis.